DNA damage checkpoints in nasopharyngeal carcinoma

Oral Oncology

Volumn 50, Issue 5, 2014, Pages 339-344

  Poon, Randy Y C ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Cell cycle; Checkpoints; DNA damage responses; Epstein Barr virus; NPC

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CYCLIN D; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; PROTEIN P16; PROTEIN P21; PROTEIN P53; CELL CYCLE PROTEIN;

ARTICLE; CARCINOGENESIS; DNA DAMAGE; DNA DAMAGE CHECKPOINT; EPSTEIN BARR VIRUS INFECTION; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; S PHASE CELL CYCLE CHECKPOINT; SIGNAL TRANSDUCTION; CELL CYCLE; GENETICS; METABOLISM; NASOPHARYNX TUMOR; PATHOLOGY;

CELL CYCLE; CELL CYCLE PROTEINS; DNA DAMAGE; HUMANS; NASOPHARYNGEAL NEOPLASMS;

EID: 84899104417     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2014.01.009     Document Type: Article

References (81)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2 2011 69 90
2. N. Raab-Traub Epstein-Barr virus in the pathogenesis of NPC Semin Cancer Biol 12 6 2002 431 441
3. E.T. Chang, and H.O. Adami The enigmatic epidemiology of nasopharyngeal carcinoma Cancer Epidemiol Biomark Prev 15 10 2006 1765 1777
4. A.T. Chan, and E. Felip Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 20 Suppl. 4 2009 4123 4125
5. A.W. Lee, Y.F. Poon, W. Foo, S.C. Law, F.K. Cheung, and D.K. Chan et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure Int J Radiat Oncol Biol Phys 23 2 1992 261 270
6. R.A. Woo, and R.Y. Poon Cyclin-dependent kinases and S phase control in mammalian cells Cell Cycle 2 4 2003 316 324
7. E.R. Parrilla-Castellar, S.J. Arlander, and L. Karnitz Dial 9-1-1 for DNA damage: the Rad9-Hus1-Rad1 (9-1-1) clamp complex DNA Repair (Amst) 3 8-9 2004 1009 1014
8. M. Jhanwar-Uniyal BRCA1 in cancer, cell cycle and genomic stability Front Biosci 8 2003 S1107 S1117
9. Y. Wang, D. Cortez, P. Yazdi, N. Neff, S.J. Elledge, and J. Qin BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures Genes Dev 14 8 2000 927 939
10. K.A. Cimprich, and D. Cortez ATR: an essential regulator of genome integrity Nat Rev Mol Cell Biol 9 8 2008 616 627
11. E. Petermann, and K.W. Caldecott Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase Cell Cycle 5 19 2006 2203 2209
12. R. Freire, M.A. van Vugt, I. Mamely, and R.H. Medema Claspin: timing the cell cycle arrest when the genome is damaged Cell Cycle 5 24 2006 2831 2834
13. F. Bassermann, D. Frescas, D. Guardavaccaro, L. Busino, A. Peschiaroli, and M. Pagano The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint Cell 134 2 2008 256 267
14. R. Boutros, C. Dozier, and B. Ducommun The when and wheres of CDC25 phosphatases Curr Opin Cell Biol 18 2 2006 185 191
15. Y. Chen, and R.Y. Poon The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability Front Biosci 2008 135016 135029
16. A. Kramer, N. Mailand, C. Lukas, R.G. Syljuasen, C.J. Wilkinson, and E.A. Nigg et al. Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase Nat Cell Biol 6 9 2004 884 891
17. M. Melixetian, D.K. Klein, C.S. Sorensen, and K. Helin NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint Nat Cell Biol 11 10 2009 1247 1253
18. Y. Honaker, and H. Piwnica-Worms Casein kinase 1 functions as both penultimate and ultimate kinase in regulating Cdc25A destruction Oncogene 29 23 2010 3324 3334
19. J. Lee, A. Kumagai, and W.G. Dunphy Positive regulation of Wee1 by Chk1 and 14-3-3 proteins Mol Biol Cell 12 3 2001 551 563
20. C.J. Rothblum-Oviatt, C.E. Ryan, and H. Piwnica-Worms 14-3-3 Binding regulates catalytic activity of human Wee1 kinase Cell Growth Differ 12 12 2001 581 589
21. T.A. Chan, H. Hermeking, C. Lengauer, K.W. Kinzler, and B. Vogelstein 14-3-3 Sigma is required to prevent mitotic catastrophe after DNA damage Nature 401 6753 1999 616 620
22. M.Z. Zdzienicka Mammalian X ray sensitive mutants: a tool for the elucidation of the cellular response to ionizing radiation Cancer Surv 1996 28281 28293
23. N. Rhind, and P. Russell Checkpoints: it takes more than time to heal some wounds Curr Biol 10 24 2000 R908-11
24. J. Falck, J.H. Petrini, B.R. Williams, J. Lukas, and J. Bartek The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways Nat Genet 30 3 2002 290 294
25. A.J. Levine, W. Hu, and Z. Feng The P53 pathway: what questions remain to be explored? Cell Death Differ 13 6 2006 1027 1036
26. N.H. Chehab, A. Malikzay, E.S. Stavridi, and T.D. Halazonetis Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage Proc Natl Acad Sci USA 96 24 1999 13777 13782
27. S.Y. Shieh, M. Ikeda, Y. Taya, and C. Prives DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2 Cell 91 3 1997 325 334
28. N.H. Chehab, A. Malikzay, M. Appel, and T.D. Halazonetis Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53 Genes Dev 14 3 2000 278 288
29. A. Hirao, Y.Y. Kong, S. Matsuoka, A. Wakeham, J. Ruland, and H. Yoshida et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2 Science 287 5459 2000 1824 1827
30. S.Y. Shieh, J. Ahn, K. Tamai, Y. Taya, and C. Prives The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites Genes Dev 14 3 2000 289 300
31. F. Bunz, A. Dutriaux, C. Lengauer, T. Waldman, S. Zhou, and J.P. Brown et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage Science 282 5393 1998 1497 1501
32. J. Lee, J.A. Kim, V. Barbier, A. Fotedar, and R. Fotedar DNA damage triggers p21WAF1-dependent Emi1 down-regulation that maintains G2 arrest Mol Biol Cell 20 7 2009 1891 1902
33. K. McFadden, and M.A. Luftig Interplay between DNA tumor viruses and the host DNA damage response Curr Top Microbiol Immunol 2013 371229 371257
34. P.A. Nikitin, C.M. Yan, E. Forte, A. Bocedi, J.P. Tourigny, and R.E. White et al. An ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells Cell Host Microbe 8 6 2010 510 522
35. S. Bose, L.F. Yap, M. Fung, J. Starzcynski, A. Saleh, and S. Morgan et al. The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma J Pathol 217 3 2009 345 352
36. J. Dheekollu, Z. Deng, A. Wiedmer, M.D. Weitzman, and P.M. Lieberman A role for MRE11, NBS1, and recombination junctions in replication and stable maintenance of EBV episomes PLoS ONE 2 12 2007 e1257
37. J. Zhou, Z. Deng, J. Norseen, and P.M. Lieberman Regulation of Epstein-Barr virus origin of plasmid replication (OriP) by the S-phase checkpoint kinase Chk2 J Virol 84 10 2010 4979 4987
38. T. Choudhuri, S.C. Verma, K. Lan, M. Murakami, and E.S. Robertson The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block J Virol 81 12 2007 6718 6730
39. W. Deng, P.S. Pang, C.M. Tsang, P.M. Hau, Y.L. Yip, and A.L. Cheung et al. Epstein-Barr virus-encoded latent membrane protein 1 impairs G2 checkpoint in human nasopharyngeal epithelial cells through defective Chk1 activation PLoS ONE 7 6 2012 e39095
40. H.C. Chen, G.H. Chen, Y.H. Chen, W.L. Liao, C.Y. Liu, and K.P. Chang et al. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma Br J Cancer 100 6 2009 1002 1011
41. W. Shi, N.M. Alajez, C. Bastianutto, A.B. Hui, J.D. Mocanu, and E. Ito et al. Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer Int J Cancer 126 9 2010 2036 2048
42. A. Kudoh, M. Fujita, L. Zhang, N. Shirata, T. Daikoku, and Y. Sugaya et al. Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment J Biol Chem 280 9 2005 8156 8163
43. S.R. Hagemeier, E.A. Barlow, Q. Meng, and S.C. Kenney The cellular ataxia telangiectasia-mutated kinase promotes Epstein-Barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli J Virol 86 24 2012 13360 13370
44. R. Li, J. Zhu, Z. Xie, G. Liao, J. Liu, and M.R. Chen et al. Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication Cell Host Microbe 10 4 2011 390 400
45. M.T. Ko, C.Y. Su, S.C. Huang, C.H. Chen, and C.F. Hwang Overexpression of cyclin E messenger ribonucleic acid in nasopharyngeal carcinoma correlates with poor prognosis J Laryngol Otol 123 9 2009 1021 1026
46. J. Lu, M.L. He, L. Wang, Y. Chen, X. Liu, and Q. Dong et al. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2 Cancer Res 71 1 2011 225 233
47. M.T. Gonzalez Serrano, M.J. Rios Moreno, M. de Miguel Rodriguez, F. Casco, H. Galera-Ruiz, and M.T. Vargas de los Monteros et al. Molecular findings of nasopharyngeal carcinoma in a European population Anal Quant Cytol Histol 33 6 2011 316 322
48. C. Huang, H. Tang, W. Zhang, X. She, Q. Liao, and X. Li et al. Integrated analysis of multiple gene expression profiling datasets revealed novel gene signatures and molecular markers in nasopharyngeal carcinoma Cancer Epidemiol Biomar Prev 21 1 2012 166 175
49. X. Liu, X.B. Lv, X.P. Wang, Y. Sang, S. Xu, and K. Hu et al. MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene Cell Cycle 11 13 2012 2495 2506
50. Q. Jiang, C. Mai, H. Yang, Q. Wu, S. Hua, and Y. Chen et al. Nuclear expression of CDK4 correlates with disease progression and poor prognosis in human nasopharyngeal carcinoma Histopathol 2013
51. C.F. Hwang, C.L. Cho, C.C. Huang, J.S. Wang, Y.L. Shih, and C.Y. Su et al. Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy Ann Oncol 13 8 2002 1246 1251
52. G.L. Wang, K.W. Lo, K.S. Tsang, N.Y. Chung, Y.S. Tsang, and S.T. Cheung et al. Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma Br J Cancer 81 7 1999 1122 1126
53. A.A. Makitie, C. MacMillan, J. Ho, W. Shi, A. Lee, and B. O'Sullivan et al. Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma Clin Cancer Res 9 6 2003 2177 2184
54. A.W. Lee, J.H. Li, W. Shi, A. Li, E. Ng, and T.J. Liu et al. P16 gene therapy: a potentially efficacious modality for nasopharyngeal carcinoma Mol Cancer Ther 2 10 2003 961 969
55. INK4a expression Oncogene 19 16 2000 2002 2013
56. Y. Shi, Y. Tao, Y. Jiang, Y. Xu, B. Yan, and X. Chen et al. Nuclear epidermal growth factor receptor interacts with transcriptional intermediary factor 2 to activate cyclin D1 gene expression triggered by the oncoprotein latent membrane protein 1 Carcinogenesis 33 8 2012 1468 1478
57. INK4a-RB pathway by promoting nuclear export of E2F4/5 J Cell Biol 162 2 2003 173 183
58. A. Saha, S. Halder, S.K. Upadhyay, J. Lu, P. Kumar, and M. Murakami et al. Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1 PLoS Pathog 7 2 2011 e1001275
59. ARF expression Proc Natl Acad Sci USA 108 5 2011 1919 1924
60. INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP PLoS Pathog 6 6 2010 e1000951
61. J.S. Knight, N. Sharma, and E.S. Robertson Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase Proc Natl Acad Sci USA 102 51 2005 18562 18566
62. J. Macdiarmid, D. Stevenson, D.H. Campbell, and J.B. Wilson The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus: paradoxes resolve to cooperation in carcinogenesis in vivo Carcinogenesis 24 7 2003 1209 1218
63. C.M. Tsang, Y.L. Yip, K.W. Lo, W. Deng, K.F. To, and P.M. Hau et al. Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells Proc Natl Acad Sci USA 109 50 2012 E3473 E3482
64. P. Effert, R. McCoy, M. Abdel-Hamid, K. Flynn, Q. Zhang, and P. Busson et al. Alterations of the p53 gene in nasopharyngeal carcinoma J Virol 66 6 1992 3768 3775
65. M.K. Chen, H.S. Lee, J.H. Chang, and C.C. Chang Expression of p53 protein and primary tumour volume in patients with nasopharyngeal carcinoma J Otolaryngol 33 5 2004 304 307
66. J. Kwong, K.W. Lo, K.F. To, P.M. Teo, P.J. Johnson, and D.P. Huang Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma Clin Cancer Res 8 1 2002 131 137
67. Y. Sun, H. Yi, Y. Yang, Y. Yu, Y. Ouyang, and F. Yang et al. Functional characterization of p53 in nasopharyngeal carcinoma by stable shRNA expression Int J Oncol 34 4 2009 1017 1027
68. T. Crook, J.M. Nicholls, L. Brooks, J. O'Nions, and M.J. Allday High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? Oncogene 19 30 2000 3439 3444
69. B. Yi, S.X. Tan, C.E. Tang, W.G. Huang, A.L. Cheng, and C. Li et al. Inactivation of 14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal carcinoma J Cell Biochem 106 5 2009 858 866
70. C. Yi, Q. Wang, L. Wang, Y. Huang, L. Li, and L. Liu et al. MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma Oncogene 31 41 2012 4421 4433
71. R.Y.C. Poon, H. Toyoshima, and T. Hunter Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation Mol Biol Cell 6 9 1995 1197 1213
72. Y. Baba, M. Tsukuda, I. Mochimatsu, S. Furukawa, H. Kagata, and K. Satake et al. Reduced expression of p16 and p27 proteins in nasopharyngeal carcinoma Cancer Detect Prev 25 5 2001 414 419
73. Y. Pan, Q. Zhang, L. Tian, X. Wang, X. Fan, and H. Zhang et al. Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma Cancer Res 72 7 2012 1890 1900
74. A. Saha, M. Murakami, P. Kumar, B. Bajaj, K. Sims, and E.S. Robertson Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2 J Virol 83 9 2009 4652 4669
75. F. Yi, A. Saha, M. Murakami, P. Kumar, J.S. Knight, and Q. Cai et al. Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities Virology 388 2 2009 236 247
76. Skp2 complex targeted by Epstein-Barr virus essential nuclear antigen Mol Cell Biol 25 5 2005 1749 1763
77. H.C. Wu, T.Y. Lu, J.J. Lee, J.K. Hwang, Y.J. Lin, and C.K. Wang et al. MDM2 expression in EBV-infected nasopharyngeal carcinoma cells Lab Invest 84 12 2004 1547 1556
78. S. Gastaldello, S. Hildebrand, O. Faridani, S. Callegari, M. Palmkvist, and C. Di Guglielmo et al. A deneddylase encoded by Epstein-Barr virus promotes viral DNA replication by regulating the activity of cullin-RING ligases Nat Cell Biol 12 4 2010 351 361
79. Z. Feng, S. Xu, M. Liu, Y.X. Zeng, and T. Kang Chk1 inhibitor Go6976 enhances the sensitivity of nasopharyngeal carcinoma cells to radiotherapy and chemotherapy in vitro and in vivo Cancer Lett 297 2 2010 190 197
80. A.K. Cheung, J.C. Ip, H.L. Lung, J.Z. Wu, S.W. Tsao, and M.L. Lung Polo-like kinase inhibitor Ro5203280 has potent antitumor activity in nasopharyngeal carcinoma Mol Cancer Ther 12 8 2013 1393 1401
81. J.P. Chow, W.Y. Man, M. Mao, H. Chen, F. Cheung, and J. Nicholls et al. PARP1 is overexpressed in nasopharyngeal carcinoma and its inhibition enhances radiotherapy Mol Cancer Ther 2013